Having survived the cancer which took his father, Graham Heron, from Bovington, is urging more men to act quickly to avoid falling victim to ...

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

John Tesh says he has outlived a terminal cancer prognosis by nearly eight years while continuing treatment for metastatic prostate cancer.

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and dosage goals.

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

An analysis of data from the NCI Cohort Consortium Physical Activity and Cancer work group explored the benefits of recommended activity levels for cancer survivors.

The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

For more information about Candel, visit: www.candeltx.com.

The American Cancer Society estimates more than 20,000 Arkansans will be diagnosed with some form of cancer this year. Cancer survival rates are at a historic high, but medical professionals are ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...